Liver resection for multifocal hepatocellular carcinoma: is it an option?
作者机构:Division of Hepatobiliary&General SurgeryDepartment of SurgeryIRCCSRozzanoMilan Pathology UnitHumanitas Clinical and Research CenterIRCCSRozzanoMilanItaly Department of Biomedical SciencesHumanitas UniversityRozzanoMilanItaly
出 版 物:《Hepatobiliary Surgery and Nutrition》 (肝胆外科与营养(英文))
年 卷 期:2019年第8卷第5期
页 面:530-533页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:multifocal diagnosis patients
摘 要:Hepatocellular carcinoma(HCC)is the second leadingcause of cancer-related death *** firstdiagnosis,HCC is multifocal in about 35-40%of patients(1,2).According to Western guidelines,the treatmentof multifocal(non-metastatic)HCC is well codified:transplantation is indicated for HCCs within Milan criteria(2-3 nodules≤30 mm),ablation for non-transplantableHCCs within Milan criteria,and chemoembolizationfor the remaining patients(3).